Navigation Links
S*BIO to Initiate Global Phase 3 Clinical Trials of its Novel JAK2 Inhibitor Pacritinib for Treatment of Myelofibrosis (MF)
Date:10/25/2011

SINGAPORE, Oct. 25, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced plans to initiate a global Phase 3 clinical program of its novel JAK2 inhibitor pacritinib (SB1518), in the first half of 2012 to further demonstrate its activity and tolerability for the treatment of myelofibrosis (MF). The company is actively exploring partnering opportunities for the advancement of its leading JAK2 program.

"Data from Phase 1 and 2 clinical studies have demonstrated that pacritinib is well tolerated and active in the treatment of myelofibrosis, an orphan disease with a high unmet medical need," said Tamar Howson, interim CEO and board member of S*BIO. "We are moving forward with an aggressive and focused development plan with global Phase 3 trials for pacritinib to further demonstrate its clinical benefits in MF patients and to maximise the value of our JAK2 program. We are currently in the process of identifying a suitable partner for the Phase 3 studies and pacritinib's subsequent commercialization."

The primary objective of the double-blind, placebo-controlled Phase 3 studies is to compare the efficacy of pacritinib versus placebo in achieving clinically significant reduction in spleen size in MF patients with splenomegaly. Secondary outcomes of both studies include patient-reported change in the most bothersome symptom identified at baseline, duration of response, as well as overall survival. The trials will enrol up to 500 MF patients.

In Phase 2 studies, treatment with pacritinib resulted in sustained reduction in MF-associated splenomegaly with no evidence of myelosuppression and no exacerbation of cytopenias. Pacritinib is a small molecule JAK2-selective kinase inhibitor that demonstrated high potency in preclinical models against both the wild type JAK2 kinase and the JAK2 kinase with the V617F mutation. The V617F mutation is found in high frequency in myeloproliferative disorders such as MF. More than 50% of patients with MF possess the JAK2
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
2. S*BIO Restructures Agreement With Onyx for JAK2 Inhibitor Program
3. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
4. S*BIOs JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission (EC) for the Treatment of Myelofibrosis (MF)
5. S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis
6. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
7. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
8. Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
9. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
10. CareFusion Initiates Class I Recall of EnVe Ventilators
11. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 ... DMPI) ("DelMar" "the Company") today announced the filing of ... recently changed its fiscal year end to June 30th ... common stock on a national securities exchange in the ... filed with the United States Securities Exchange Commission can ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 1, 2012 Heart IT, the global leader ... medical imaging workstation, WebPAX®, announced today the award ... viewing technologies. "Zero-footprint" technologies allow health care professionals ... with a standard Internet web browser. ...
... (NASDAQ: ANGN ) today announced it has ... Global Sales effective May 7, 2012. Mr. Margolies will ... worldwide sales organization and delivering sales results to achieve ... Mr. Margolies will be succeeding James Gaul, senior vice ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 2Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 3Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 4
(Date:9/1/2014)... (PRWEB) September 01, 2014 Developers of FCPX ... tutorial video for the ProWorld Plugin from Pixel Film Studios. ... Pro X can do and users now have the ability ... Said Christina Austin, CEO of Pixel Film Studios. “Blurring the ... changer.” , Learn how to turn a 2D HDRI image ...
(Date:8/31/2014)... D.C.USA (PRWEB) August 31, 2014 ... global community utilizing social media marketing tools access ... interactive programs. MMU will utilize all tools to ... learning partner for our multiple learning channels. , ... mobile app, and an authoring tool that applies ...
(Date:8/31/2014)... September 01, 2014 Recently, BambooIndustry.com, one of ... website with a new selection of bamboo veneers . ... 25 percent off) for these high quality products. The promotion ... company’s senior spokesman says that its top quality veneers are ... unveil the new designs of bamboo veneers. All these items ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 LabDoor.com tests ... vitamins and supplements. According to their website, “We buy ... - through retail stores and online sites. No manufacturer-supplied ... mission to “Stay Healthy with LabDoor,” a recent study ... D supplements in the United States for Vitamin ...
(Date:8/31/2014)... Top10BestSEOHosting.com, a reliable review website, has ... that FatCow, Arvixe and Hostgator are the best ASP.NET ... ASP.NET hosting companies in the world, but good suppliers ... run a reliable ASP.NET server than running a Linux ... firmly believe that FatCow, Arvixe and Hostgator are the ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2
... treatment is a safe and precise method for removal ... the first report on "self-embedding disorder," or self-injury and ... be presented today at the annual meeting of the ... in a unique position to be the first to ...
... functional MRI (fMRI) have determined that the circuitry in ... is dysfunctional in patients suffering from stress-related psychiatric disorders. ... the annual meeting of the Radiological Society of North ... and other stress-related disorders, traumatic memories are a source ...
... Minimally invasive, image-,guided treatment is a safe and ... body, according to the first report on "self-,embedding disorder," ... findings will be presented today at the annual meeting ... "Radiologists are in a ...
... how our brains build meaningful images from the bits of ... Grawemeyer Award for Psychology. , Anne Treisman, ... Princeton University , was selected for the ninth Grawemeyer,psychology prize ... Treisman, a cognitive psychologist, proposed in 1980 that attention ...
... times as likely as all other children and almost ... uninsured, according to a report in the December issue ... the JAMA/Archives journals. , Children of farm workers face ... in the article. Most are Latino, a group that ...
... SAN FRANCISCO, Dec. 2 At a symposium ... Baltimore, Maryland, Posit Science researchers presented,the latest research ... translating the,science into technology to improve lives. Henry ... cognitive intervention developed by,Posit Science can facilitate neuroplasticity, ...
Cached Medicine News:Health News:Radiologists diagnose and treat self-embedding disorder in teens 2Health News:Stress-related disorders affect brain’s processing of memory 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 3Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:1/3 of farm workers' children lack health insurance 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2
... Trauma and Increase Staff Protection With Medline's Sterile ... 14 Fr, 16 Fr and 18 Fr), ... in the U.S. We manufacture most of our ... or exceeds our customers' expectations. We manufacture, supply ...
Sterile Straight Packed TOUCH-TROL Suction Catheters...
... in two tip styles- the ... staggered eyes, and the angled ... catheter valve options, SAFE-T-VAC and ... with virtually no residual vacuum ...
... Our Tri-Flo® suction catheter design ... to your patients while still providing ... pediatric catheters (5/6, 8 or 10 ... facilitate proper catheter placement. Our complete ...
Medicine Products: